COMP <GO>
PRIM vs TMO // OPERATING MARGIN
Primoris Services Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PRIM 7
— TMO 7
▲ OPERATING MARGIN LEADER: TMO
LAST: $72.77 (-3.76%) • MKT CAP: $4.07B
operating-margins
5.40%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRIM VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRIM | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 10.70% | 41.00% | -30.30 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.90% | 9.30% | +11.60 | PRIM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.6x | 30.4x | -22.80 | PRIM | /valuation <GO> |
| Free Cash Flow Yield | 8.37% | 2.40% | +5.97 | PRIM | /fcf-yield <GO> |
| Operating Margin ACTIVE | 5.40% | 17.40% | -12.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 3.60% | 15.10% | -11.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 19.00% | 3.90% | +15.10 | PRIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.43% | 0.24% | +0.19 | PRIM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.49 | 4.50 | -1.01 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.70% | +0.70 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.3 | 59.1 | -11.90 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.14 | 0.94 | +0.20 | PRIM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.4x | 36.3x | -23.90 | PRIM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.07B | $262.22B | -$258.15B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRIM REV | TMO REV | PRIM GROSS % | TMO GROSS % | PRIM FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.57B | $44.56B | 10.7% | 44.0% | $340.5M | $6.29B |
| FY 2024 | $6.37B | $42.88B | 11.0% | 44.0% | $381.8M | $7.27B |
| FY 2023 | $5.72B | $42.86B | 44.0% | 44.0% | -$58.7M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRIM // BETA 1.14
TMO // BETA 0.94